Join to View Full Profile
1301 Palm AveJacksonville, FL 32207
Phone+1 904-202-7300
Fax+1 904-202-2754
Dr. Cavaliere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterFellowship, Neuro-Oncology, 2003 - 2005- University of Virginia Medical CenterResidency, Neurology, 2000 - 2003
Westchester Medical CenterInternship, Internal Medicine, 1999 - 2000
New York Medical CollegeClass of 1999
Certifications & Licensure
FL State Medical License 2015 - 2026
OH State Medical License 2005 - 2017
VA State Medical License 2000 - 2006
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Sunitinib in Treating Patients With Recurrent Malignant Gliomas Start of enrollment: 2007 Jun 01
- Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
- LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma Start of enrollment: 2020 Oct 21
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCorrection to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomesI-Chia Liu, Adam L. Holtzman, Ronny L Rotondo, Daniel J. Indelicato, Sridharan Gururangan
Journal of Neuro-Oncology. 2021-07-01 - 6 citationsProton therapy for adult medulloblastoma: Acute toxicity and disease control outcomesI-C Hia Liu, Adam L. Holtzman, Ronny L Rotondo, Daniel J. Indelicato, Sridharan Gururangan
Journal of Neuro-Oncology. 2021-06-08 - 16 citationsA phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignanciesKatharine Collier, Hugo Valencia, Herbert B. Newton, Erinn M. Hade, Douglas W. Sborov
Cancer Chemotherapy and Pharmacology. 2021-01-25
Press Mentions
Mason Health Welcomes New Specialty Providers: Danielle Blood, MD, Robert Cavaliere, DPM, and Ross Vogelgesang, MDOctober 5th, 2021- The Players Tees up Big Surprise for Young Cancer PatientsMarch 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
